Calling for Sickle Cell Trait research.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
65pct
2d open
vs 957 other HRES bills in the 114th — cohort avg 14d
Recognizes the challenges in addressing health outcomes among people with Sickle Cell Trait and Sickle Cell Disease. Encourages the medical community to make individuals aware of their Sickle Cell Trait status. Urges the Department of Health and Human Services to develop a public awareness campaign regarding the importance of individuals knowing their Sickle Cell Trait status and to expand access for screening and counseling. Commits to supporting research on Sickle Cell Trait and Sickle Cell Disease.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2016 · first_quarter · Medical/Disease Research/Clinical Labs
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests
Client expense: $30,000 · Firm income: Not reported
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2015 · fourth_quarter · Medical/Disease Research/Clinical Labs
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2015 · third_quarter · Medical/Disease Research/Clinical Labs
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative regulation of laboratory developed tests
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2015 · second_quarter · Medical/Disease Research/Clinical Labs
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6)
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
| Democratic |
| NY |
| Danny K. Davis | Democratic | IL |
| Debbie Dingell | Democratic | MI |
| Debbie Wasserman Schultz | Democratic | FL |
| Gregory W. Meeks | Democratic | NY |
| John Conyers, Jr. | Democratic | MI |
| Michael C. Burgess | Republican | TX |
| Mike Thompson | Democratic | CA |